• 1st longer term tirzepatide study (3 years)

  • Nov 14 2024
  • Length: 45 mins
  • Podcast

1st longer term tirzepatide study (3 years)

  • Summary

  • Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis.

    Learn:

    • If people lose weight and keep it off with tirzepatide
    • How many people regain weight after stopping the medicine
    • Long-term side effects
    • If semaglutide helps with osteoarthritis

    Click here to read the tirzepatide study

    Click here to read the semaglutide study

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 1st longer term tirzepatide study (3 years)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.